Sphingosine kinase and p38 MAP kinase signaling promote resistance to arsenite-induced lethality in Caenorhabditis elegan

被引:1
|
作者
Kim, Sungjin [1 ]
Sieburth, Derek [1 ,2 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA
关键词
Sphingosine kinase; Oxidative stress; PMK-1; SKN-1; INDUCED OXIDATIVE STRESS; INDUCED APOPTOSIS; PRESYNAPTIC TERMINALS; PROTEIN-KINASE; C-ELEGANS; CERAMIDE; PATHWAY; SPHINGOSINE-1-PHOSPHATE; TRANSLOCATION; MITOCHONDRIA;
D O I
10.1007/s13273-019-0045-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Backgrounds Arsenite is a naturally occurring mitochondrial toxin that generates oxidative stress in vivo. Previously, we have reported that SPHK-1/sphingosine kinase plays a critical role in promoting survival following arsenite exposure in C. elegans. However, the molecular mechanism by which SPHK-1 confers resistance to arsenite-induced toxicity is not known. Methods Using a combination of genetic, fluorescence imaging, and behavioral approaches, we addressed the cellular and molecular mechanism by which SPHK-1 signaling protects animals from arsenite-induced lethality. Results SPHK-1 kinase activity and localization to mitochondria are required for protection from arsenite-induced lethality. Genetic alterations leading to low SPH levels promote resistance to arsenite-mediated toxicity. SPHK-1 functions in the PMK-1/p38 MAPK pathways in the intestine to promote protection. Finally, sphk-1 mutants are sensitive to a range of oxidative stressors including juglone, paraquat and heat. Conclusion SPHK-1 and PMK-1 signaling play important roles in the oxidative stress response in C. elegans.
引用
收藏
页码:415 / 424
页数:10
相关论文
共 50 条
  • [31] The Third Conformation of p38α MAP Kinase Observed in Phosphorylated p38α and in Solution
    Akella, Radha
    Min, Xiaoshan
    Wu, Qiong
    Gardner, Kevin H.
    Goldsmith, Elizabeth J.
    STRUCTURE, 2010, 18 (12) : 1571 - 1578
  • [32] Benzothiazole based inhibitors of p38α MAP kinase
    Liu, Chunjian
    Lin, James
    Pitt, Sidney
    Zhang, Rosemary F.
    Sack, John S.
    Kiefer, Susan E.
    Kish, Kevin
    Doweyko, Arthur M.
    Zhang, Hongjian
    Marathe, Punit H.
    Trzaskos, James
    Mckinnon, Murray
    Dodd, John H.
    Barrish, Joel C.
    Schieven, Gary L.
    Leftheris, Katerina
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 1874 - 1879
  • [33] Mechanism of p38 MAP kinase activation in vivo
    Brancho, D
    Tanaka, N
    Jaeschke, A
    Ventura, JJ
    Kelkar, N
    Tanaka, Y
    Kyuuma, M
    Takeshita, T
    Flavell, RA
    Davis, RJ
    GENES & DEVELOPMENT, 2003, 17 (16) : 1969 - 1978
  • [34] P38 MAP kinase inhibitors for the treatment of arthritis
    Barlocco, D
    Langston, S
    DRUG DISCOVERY TODAY, 2001, 6 (15) : 808 - 809
  • [35] Synthesis of a naphthyridone p38 MAP kinase inhibitor
    Chung, John Y. L.
    Cvetovich, Raymond J.
    McLaughlin, Mark
    Amato, Joseph
    Tsay, Fuh-Rong
    Jensen, Mark
    Weissman, Steve
    Zewge, Daniel
    JOURNAL OF ORGANIC CHEMISTRY, 2006, 71 (22): : 8602 - 8609
  • [36] Imidazopyrimidines, potent inhibitors of p38 MAP kinase
    Rupert, KC
    Henry, JR
    Dodd, JH
    Wadsworth, SA
    Cavender, DE
    Olini, GC
    Fahmy, B
    Siekierka, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) : 347 - 350
  • [37] Role of p38 MAP kinase in myocardial stress
    Nagarkatti, DS
    Sha'afi, RI
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (08) : 1651 - 1664
  • [38] Immunolocalization of p38 MAP kinase in mouse brain
    Maruyama, M
    Sudo, T
    Kasuya, Y
    Shiga, T
    Hu, BR
    Osada, H
    BRAIN RESEARCH, 2000, 887 (02) : 350 - 358
  • [39] Practical Synthesis of a p38 MAP Kinase Inhibitor
    Achmatowicz, Michal
    Thiel, Oliver R.
    Wheeler, Philip
    Bernard, Charles
    Huang, Jinkun
    Larsen, Robert D.
    Faul, Margaret M.
    JOURNAL OF ORGANIC CHEMISTRY, 2009, 74 (02): : 795 - 809
  • [40] Inhibition of p38 MAP kinase as a therapeutic strategy
    Lee, JC
    Kumar, S
    Griswold, DE
    Underwood, DC
    Votta, BJ
    Adams, JL
    IMMUNOPHARMACOLOGY, 2000, 47 (2-3): : 185 - 201